Molecular genetic analysis of leucine tRNA in relevance to type 2 diabetes mellitus by Khan, Niaz Muhammad et al.
 ORIGINAL ARTICLE ISSN 2450–7458
167
Address for correspondence:  
Muhammad Waseem Khan
Department of Biotechnology
Faculty of Life Sciences and Informatics 
Balochistan University of Information Technology Engineering  
and Management Sciences 
87300, Quetta, Pakistan
Phone: +92-333-7896575
e-mail: muhammad.waseem@buitms.edu.pk
Clinical Diabetology 2020, 3, 167–173
DOI: 10.5603/DK.2020.0018
Received: 01.10.2019  Accepted: 04.05.2020
Niaz Muhammad Khan1, Hayat Ullah1, Abdur Raziq1, Adnan Ali Khan2,  
Muhammad Waseem Khan3
1Department of Bioinformatics & Biotechnology, Faculty of Life Science, Government College University Faisalabad, Pakistan 
2Department of Genetics, Hazara University Mansehra, Pakistan 
3Department of Biotechnology, Faculty of Life Sciences and Informatics, Balochistan University of Information Technology Engineering  
and Management Sciences, Quetta, Pakistan
Molecular genetic analysis of leucine tRNA 
in relevance to type 2 diabetes mellitus
ABSTRACT 
Background. Several point mutations in the mito-
chondrial DNA cause maternally inherited metabolic 
disorders. The most common type of mutation A3243G 
in the gene of transfer RNA leucine (tRNALeu(UUR)) is 
thought to be responsible for the prevalence of type 2 
diabetes mellitus. This study was designed to analyze 
the tRNALeu(UUR) gene of mtDNA of the diabetic indi-
viduals with familial history of diabetes to identify the 
point mutations A3243G. 
Material and methods. Saliva samples were preferred 
as a source of DNA to minimize the risk of infection. 
DNA was successfully extracted from their saliva. Sam-
ples of high-quality DNA was amplified with PCR and 
sequenced in Macrogen Inc. Korea. 
Results. The m.3243A>G mutation in mitochondrial 
tRNALeu(UUR) gene was not observed. 
Conclusion. The result shows that the m.3243A>G 
mutation in mitochondrial tRNALeu(UUR) gene is not 
frequent cause of type 2 and some other factors may 
be possible i.e. genetic, behavioral or environmental. 
It is recommended that the sample size for diabetic 
individuals need to be increased for a future study 
and screened for the mitochondrial as well as other 
mutations of nuclear origin. (Clin Diabetol 2020; 9; 3: 
167–173)
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Introduction
Diabetes mellitus (DM) is a common disease af-
fecting many individuals worldwide. DM encompasses 
a range of metabolic failures, characterized by hyper-
glycemia developed from impairment of beta cells of 
pancreas and mutations in genomic DNA. Genetic im-
pairment is involved in both peripheral insulin sensitivity 
and glucose linked insulin secretions. Mitochondria has 
important role in glucose insulin secretion, mutations in 
mitochondrial DNA (mtDNA) can cause insulin secretion 
impairment. In mitochondria, oxidative phosphoryla-
tion variation in the ration of intracellular adenosine 
triphosphate/adenosine diphosphate (ATP/ADP) may 
trigger the exocytosis of insulin [1].
Mitochondrial DNA follows a maternal pattern of 
inheritance [2]. More than 220 mutations have been 
related with syndromes in the 22 genes of human tRNA 
and 40 in human tRNALeu(UUR) gene. Epidemiological 
studies indicate prevalence of approximately 1 in 5,000 
mtDNA mutations in adults, making mtDNA the most 
common carriers of genetic disorders [3]. Mutations 
in mitochondrial tRNA genes are linked with multiple 
human diseases, including heart failure, neuromuscular 
disorders, diabetes, visual and hearing loss. Particularly, 
mutation at position A3243G of tRNALeu(UUR) gene 
causing MELAS Syndrome (mitochondrial encephalo-
myopathy, lactic acidosis, and stroke-like episodes) is 
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responsible for about 2% of cases of type 2 diabetes 
[4]. Point mutation A3243G in the tRNALeu(UUR) gene 
is one of the most common mtDNA defect, firstly 
diagnosed in children with MELAS Syndrome. Some 
families also express diabetes and deafness known as 
MIDD (maternally inherited diabetes and deafness) [5, 
6]. In general population, MIDD is responsible for 0.5 
to 1.5% of all diabetes cases. MIDD pathophysiological 
mechanism are complex and may involve impairment 
of glucose toxicity, insulin secretion and resistance. In 
mitochondrial diabetes, insulin impairment response 
to glucose challenge is in an early stage and indicates 
major factor in the pathogenesis of hyperglycemia. 
However, insulin response to glucagon and arginine 
rather than glucose is not clear [7, 8].
The most notorious mutation is A3243G in 
tRNALeu(UUR) gene that causes impairment in the ar-
rangement of functional proteins of Electron Transport 
Chain (ETC). This type of mutation is non-adoptive and 
brings impairment in the production of insulin [9]. 
A3243G point mutation becomes pathogenic when 
its concentration reaches 10–30%.Most commonly, 
considered as the frequent cause of insulin independent 
diabetes mellitus [10]. Mutation in tRNALeu(UUR) gene at 
position A3243G cause defects in function of tRNA to 
properly assemble proteins in respiratory chain com-
plexes due to which oxidative phosphorylation will not 
properly produce enough ATP to activate ATP-sensitive 
potassium channels in the β-cells to secrete insulin in 
response to high blood sugar level which will eventually 
cause type 2 DM. The Adenine to Guanine at nucleotide 
position A3243G in the tRNA gene play a major role 
in the methylation amino-acylation codon recognition 
and tertiary union of the molecules assembly. The muta-
tion responsible for this maternally inherited diabetes 
mellitus is varying in different ethnic groups [11, 12].
The population of tribal areas of Pakistan is less 
explored and little literature is available on this specific 
ethnic group. Therefore, this study population has 
been assessed for mitochondrial DNA mutation which 
is more frequently found in population affected with 
type 2 diabetes mellitus. The aim of this study was to 
determine mitochondrial tRNALeu(UUR) gene mutation in 
MIDD in the population of tribal areas of Pakistan as this 
might help to determine the molecular mechanism of 
the type 2 DM. Such type of finding will pave the way 
for better treatment, genetic counselling and prenatal 
diagnosis of maternally inherited diabetes.
Materials and methods
The approval of this study was obtained from 
the Hazara University Institutional Review Board and 
written informed consent was obtained from all the 
study individuals. A detailed medical history of the 
study individuals was recorded and detailed pedigree 
(Figure 1, Table 1) was drawn at the time of visit to 
the affected families. Saliva samples (5 ml) were ob-
tained from fifteen diabetic individuals and DNA was 
extracted successfully. Only five (N = 5) samples had 
optimum quantity of DNA required for sequencing. 
The collected amount of saliva 5 ml was important 
to get high amount of buccal epithelial cells for high 
concentration of the genomic DNA. The samples were 
stored at –20 °C soon after collection to recede the risk 
of contamination. 
DNA extraction and PCR amplification
Genomic DNA was extracted from buccal epithelial 
cells using a modified protocol [13]. The extracted DNA 
was quantified using NanoDrop measurement at ratio 
of absorbance at 260/280 nm as shown in Table 2. 
After quantification whole genomic mitochondrial 
DNA was amplified using standard kit method (Qiagen 
Repli-G mitochondrial DNA kit). The fragments encom-
passing np 3243 of mitochondrial DNA were amplified 
with PCR using AmpliTaq DNA polymerase. The sets of 
reverse and forward primer were used. The nucleotide 
sequence of forward primer was F-5’-CAAATTCCTCC-
CTGTACGAAAGG-3’ and the reverse primer was R-5’- 
-AATGAGGAGTAGGAGGTTGGCC-3’. PCR was carried out 
in a total volume of 25 μl master mix containing 50 ng 
of extracted DNA, 2.0 μl each dNTP, 11.5 μl ddH2O, 
2.5 μl MgCl2, and 0.5 μl of Taq polymerase. The DNA 
was initially denatured at 94°C for 3 min and subjected 
to 35 PCR cycles of 94°C for 45 sec, 59°C for 1 min, and 
72°C for 3 min. The PCR products after amplification 
were electrophoresed on 1% agarose gel and stained 
with ethidium bromide (Figure 2).
Gene clean
TIANgel Midi Purification Kit, Cat# DP209-02.PCR 
was used according to manufacturer’s instructions for 
elution of the PCR amplificated DNA.
Sanger sequencing of the targeted  
mtDNA region
DNA sequencing were carried out using the Big-
Dye terminator cycle sequencing method and reaction 
products were analyzed on an ABI-Prism 377 au-
tomated sequencer at Macrogen Inc. Korea (www.
macrogen.com).
The resulted sequencing data was analyzed us-
ing NCBI online tool BLAST. The revised Cambridge 
Reference Sequence (rCRS) of human mitochondrial 
DNA was used as reference for analysis of the DNA 
samples. 
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Results 
Individual’s clinical and social history was recorded 
with the help of questionnaires. Characteristics of the 
individuals and most common clinical complications 
related to type 2 DM are presented in Table 1. The 
tRNALeu(UUR) gene from the proband N_1, N_2, N_4 
and N_5 from the diabetic families were sequenced. 
Sample 3 (N_3) was wasted and not included in the 
Table 1. Characteristics and clinical history of all the study subjects (N = 5)
Sample number Gender Age (years) Weight [kg] Complications Medications
N_1 Male 60 60 Renal disease Insulin 
N_2 Male 55 75 Blindness, joint problems,  
high blood pressure
Oral hypoglycemic agent
N_3 Female 50 65 Joint pain, infertility,  
skin and renal disease
Insulin
N_4 Male 43 80 High blood pressure, hearing loss, 
renal and heart disease
Oral hypoglycemic agent
N_5 Male 75 55 High blood pressure, renal disease Insulin
Table 2. DNA concentrations of samples (N = 5)
Sample number DNA concentration [ng/μl]
N_1 1.81
N_2 1.96
N_3 1.78
N_4 1.90
N_5 1.84
Figure 1. Family pedigree of all the three families (A, B and C) including three generations. The circles represent the female 
members while the squares representing the male members. Black square and circles represent the diseased one and white show 
the normal non diseased one. N_1 to N_5 are the type 2 diabetes individuals inlcuded in the final analysis
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final analysis. Sequences were aligned using online 
tool using NCBI. The obtained sequence data samples 
were aligned with rCRS with accession No NC-012920.1 
(Figure 3). After careful analysis of sequenced data, 
point mutation tRNALeu(UUR) gene at position 3243 A-G 
was not observed.
Discussions
In Pakistan, presently 6.9 million individuals suffer 
from diabetes. It is assumed that by 2030, Pakistan 
will be ranked fifth for residing most number of DM 
individuals [14]. The inheritance of diabetes is different 
in different ethnic groups i.e. some ethnic groups in 
a particular area are more affected than others. Also, 
social, behavioral and environmental factors contribute 
to the onset of disease [15, 16]. Pakistani tribal areas are 
still not explored with respect to mtDNA mutation as-
sociated with MIDD. In this research study, we assessed 
and analyzed mtDNA tRNALeu(UUR) gene mutation in 
families suffering from diabetes, living in tribal areas of 
Pakistan. During recording of the questionnaires, most 
of the individuals had experienced emotional stress 
before the onset of type 2 DM. Emotional stress is a 
risk factor for type 2 DM that should also be considered 
[17]. The outcomes of the current study for mutation in 
mitochondrial tRNALeu(UUR) gene in subjects with type 2 
DM in population from tribal areas of Pakistan identi-
fied none of the individual as a carrier of this mutation. 
Diabetes mellitus is a group of metabolic disor-
ders such as destruction of beta cells of pancreas and 
genomic DNA mutations in genes linked to type 2 DM 
[18]. Gene mutations are involved in peripheral insu-
lin sensitivity and glucose induced insulin secretions. 
mtDNA has 10 times more spontaneous mutations as 
compared with nuclear genome and is responsible for 
more than 80% of MELAS cases due to lack of protec-
tive histone and DNA repair system [19]. Therefore, 
mitochondrial DNA mutation may lead to impaired in-
sulin secretion due to its role in glucose induced insulin 
secretion in pancreatic beta cells and pancreatic islets 
cells easily effected by disturbance of oxidative phos-
phorylation. Diabetes mellitus associated with mtDNA 
is transmitted maternally while the most common 
point mutation associated with DM was mitochondrial 
DNA tRNA gene (i.e. A3243G). Pakistani population is 
not explored in respect to disease associated with mi-
tochondria particularly type 2 DM in relation with mt 
tRNA-Leu gene [20]. It is still not explored that which 
type of mtDNA mutation is responsible for type 2 DM.
In mtDNA, point mutations can occur due to dele-
tion, insertion and substitution of nucleotide so com-
prehensive analysis and screening of entire mtDNA is 
required. However, the ratio of mutated mtDNA varies 
between tissues in relation to wild type mtDNA, being 
high ratio in post mitotic tissues (pancreas, brain and 
skeletal muscles) while low in rapidly dividing tissues 
(blood leukocytes). According to a study from Hart et 
al., the defect in the mitochondrial tRNALeu(UUR) gene 
is associated with type 2 DM [11]. Martikainen et al. 
reported that 1% of DM emergence associated with 
A3243G mutation in mtDNA tRNALeu(UUR) gene [21]. 
The response of impaired insulin to glucose in patients 
with tRNALeu(UUR) gene mutation is an early and criti-
cal abnormality in the development of type 2 DM [7]. 
However, it should not be excluded that other muta-
tions such as tRNAGlu 14709 T Æ C, ND-13316 G Æ A, 
Figure 2. PCR amplified tRNALeu(UUR) gene products from sample N_1 to N_5 of 227 bp DNA fragments, L = 100 bp DNA marker
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ND-13394 T Æ C, ND-13426 A Æ G, ND-412026 A Æ G, 
tRNALeu 3256 C Æ T, tRNALys8296 A Æ G, tRNALys8344 
A Æ G, tRNALys8363 G Æ A, tRNASer 12258 C Æ A 
in genes have active role in etiology of disease [22].
The pathogenic mutation in the mitochondrial 
genome is very common due to the lack of efficient 
mitochondrial DNA mutation repair machinery. The 
mitochondrial genome has overlapping coding regions 
and mutation in any region can cause severe phenotypic 
effects. Since 1988, more than 270-point mutations 
have been described, affecting every mtDNA gene. 
Remarkably, more than half of these mutations are 
located in tRNA genes, even though tRNA comprise only 
about 10% of the total coding capacity of the genome. 
Among the point mutations the most common are an 
AÆG transition at position 3243 in the tRNALeu(UUR) 
gene. It was long believed that AÆG transition at posi-
tion 3243 in the tRNALeu(UUR) gene is the common cause 
of type 2 DM [23, 24].
The leucine tRNA gene in the mitochondrial 
genome appears to be a frequent spot for point 
mutations, as several different mutations have been 
described so far. The most common mutation occurs 
at base pair (bp) 3243, and it accounts for approxi-
Figure 3. Sequence alignment of sample N_1 to N_5 obtained from Macrogen (www.macrogen.com) with revised Cambridge 
Reference Sequence (rCRS) of human mitochondrial DNA (Accession NO-012920.1)
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mately 80% of cases of the MELAS syndrome. For this 
reason, mtDNA testing were preferred while MODY 
has a high inheritance rate and represents one end 
of a continuum of monogenic forms of diabetes that 
includes neonatal diabetes [25, 26]. The frequency of 
the A3243G mutation in mitochondrial tRNALeu(UUR) 
gene vary in the members of different ethnicities. In 
a study conducted for the confirmation of A3243G 
mutation in tRNALeu(UUR) gene being the frequent cause 
of type 2 DM has concluded that this mutation is not 
the frequent cause of type 2 DM [27].
In this study, all the selected families had type 2 
DM familial vertical history. The clinical description 
included phenotypic features including sensorineural 
hearing loss, diabetes mellitus, cardiovascular disease, 
renal disease, blindness, arthritis, hypertension, and 
infertility. Other potential diabetic phenotypes include 
noninsulin-dependent diabetes mellitus (NIDDM), insu-
lin-dependent diabetes mellitus (IDDM), malnutrition 
related diabetes mellitus (MRDM) and other diabetes 
associated syndromes such as Wolfram syndrome-
diabetes insipidus, diabetes mellitus, optic atrophy, and 
deafness (DIDMOAD) and Maturity-onset diabetes of 
the young (MODY) [28]. NIDDM is a heterogeneous dis-
order with different pattern of inheritance that appears 
after forty year of age and is characterized by defect in 
beta cell function and insulin resistance [29]. IDDM is 
a polygenic disease characterized by defects in secre-
tion and action of insulin. Several molecular alteration 
such as decrease in receptor tyrosine kinase activity, 
insulin receptor number, and IRS-1 phosphorylation 
contribute to insulin resistance [30]. MRDM also known 
as tropical pancreatic diabetes mellitus is rare diabetes 
linked with long term malnutrition, characterized by 
hyperglycaemia, insulin resistance, insulinopenia, and 
dysfunctional of the beta cells of pancreas [31]. DID-
MOAD is a mitochondrial DNA disorder, can cause DM 
as the start of symptoms [32]. MODY is a monogenic 
disorders in seven different genes mutations lead to 
alter secretion of insulin [33]. Some diabetic patient, 
diagnosed as type 2 DM do not indicate evidence of cir-
culating autoantibodies and overweight, are medicated 
using oral hypoglycemic drugs. This type of diabetes 
is classified as latent autoimmune diabetes of adults 
(LADA) [34]. 
The outcomes of the current study for mutation 
in mitochondrial tRNALeu(UUR) gene in subjects with 
type 2 DM in population from tribal areas of Pakistan 
identified none of the individual as a carrier of A3243G 
mutation in tRNALeu(UUR) gene. The mitochondrial DNA 
is highly vulnerable to pathogenic mutation almost at 
any site, therefore in the etiology of this disease other 
gene variation should not be excluded. The clinical 
spectrum of mtDNA mutations are extremely broad, 
identical clinical signs and symptoms can be caused 
by nuclear genes and mtDNA mutations. If the suspect 
are obese or overweight with fasting hyperglycaemia, 
glycosuria in the presence of normoglycaemia and hav-
ing strong family history of DM recommends mtDNA 
tests. Also, the large sample size and comprehensive 
sequencing of the entire mtDNA molecule is needed 
in Pakistani population.
Acknowledgement
Authors would like to thank the lab technician and 
volunteers who participated in this study.
Conflict of interest
The authors declare that they do not have any 
competing interests.
REFERENCES
1. Naveed A, Wahid M, Naveed A. Mitochondrial tRNALeu(UUR) 
gene mutation and maternally inherited diabetes mellitus in 
Pakistani population. Int J Diabetes Mellit. 2009; 1(1): 11–15, 
doi: 10.1016/j.ijdm.2009.03.012.
2. Greiner S, Sobanski J, Bock R. Why are most organelle genomes 
transmitted maternally? BioEssays. 2014; 37(1): 80–94, doi: 
10.1002/bies.201400110.
3. Wang M, Zhou XL, Liu RJ, et al. Multilevel functional and struc-
tural defects induced by two pathogenic mitochondrial tRNA 
mutations. Biochem J. 2013; 453(3): 455–465, doi: 10.1042/
bj20130294.
4. Li R, Guan MX. Human mitochondrial leucyl-trna synthetase 
corrects mitochondrial dysfunctions due to the tRNALeu(UUR) 
A3243G mutation, associated with mitochondrial encephalomyo-
pathy, lactic acidosis, and stroke-like symptoms and diabetes. Mol 
Cell Biol. 2010; 30(9): 2147–2154, doi: 10.1128/mcb.01614-09.
5. Guery B. The spectrum of systemic involvement in adults pre-
senting with renal lesion and mitochondrial tRNA(Leu) gene 
mutation. Journal of the American Society of Nephrology. 2003; 
14(8): 2099–2108, doi: 10.1097/01.asn.0000080180.51098.02.
6. Schon E, DiMauro S, Hirano M. Human mitochondrial DNA: roles 
of inherited and somatic mutations. Nat Rev Genet. 2012; 13(12): 
878–890, doi: 10.1038/nrg3275.
7. Brandle M, Lehmann R, Maly FE, et al. Diminished insulin secretory 
response to glucose but normal insulin and glucagon secretory 
responses to arginine in a family with maternally inherited dia-
betes and deafness caused by mitochondrial tRNALEU(UUR) gene 
mutation. Diabetes Care. 2001; 24(7): 1253–1258, doi: 10.2337/
diacare.24.7.1253.
8. Gerbitz KD, Gempel K, Brdiczka D. Mitochondria and diabetes: 
genetic, biochemical, and clinical implications of the cellular 
energy circuit. Diabetes. 1996; 45(2): 113–126, doi: 10.2337/
diab.45.2.113.
9. Nile D, Brown A, Kumaheri M, et al. Age-Related mitochondrial 
DNA depletion and the impact on pancreatic beta cell func-
tion. PLoS ONE. 2014; 9(12): e115433, doi: 10.1371/journal.
pone.0115433.
10. Schaefer A, Walker M, Turnbull D, et al. Endocrine disorders in 
mitochondrial disease. Mol Cell Endocrinol. 2013; 379(1-2): 2–11, 
doi: 10.1016/j.mce.2013.06.004.
11. Hart LM’t, Hansen T, Rietveld I, et al. Evidence that the mitochon-
drial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 
diabetes susceptibility gene. Diabetes. 2005; 54(6): 1892–1895, 
doi: 10.2337/diabetes.54.6.1892.
Niaz Muhammad Khan et al., Molecular genetic analysis of leucine tRNA in relevance to type 2 diabetes mellitus
173
12. Park H, Davidson E, King M. The pathogenic A3243G mutation 
in human mitochondrial tRNALeu(UUR) decreases the efficiency 
of aminoacylation†. Biochemistry. 2003; 42(4): 958–964, doi: 
10.1021/bi026882r.
13. Aidar M, Line S. A simple and cost-effective protocol for DNA 
isolation from buccal epithelial cells. Braz Dent J. 2007; 18(2): 
148–152, doi: 10.1590/s0103-64402007000200012.
14. Latif A, Ghafoor A, Wali A, et al. Did diabetes mellitus affect 
treatment outcome in drug-resistant tuberculosis patients in 
Pakistan from 2010 to 2014? Public Health Action. 2018; 8(1): 
14–19, doi: 10.5588/pha.17.0098.
15. Reinehr T. Type 2 diabetes mellitus in children and adolescents. 
World J Diabetes. 2013; 4(6): 270–281, doi: 10.4239/wjd.
v4.i6.270.
16. Razaq S, Khan MW, Masood Z, et al. et al.. An investigation on 
the prevalance of gestational diabetes mellitus in the pregnant 
women of province balochistan. WJMS. 2015; 12(2): 198–203, 
doi: 10.5829/idosi.wjms.2015.12.2.93229.
17. Brown LC, Majumdar SR, Newman SC, et al. History of depres-
sion increases risk of type 2 diabetes in younger adults. Diabetes 
Care. 2005; 28(5): 1063–1067, doi: 10.2337/diacare.28.5.1063.
18. Wahid M, Naveed AK, Hussain I. Insulin and glucagon ratio in 
the pathophysiology of diabetic ketoacidosis and hyperosmolar 
hyperglycemic non-ketotic diabetes. J Coll Physicians Surg Pak. 
2006; 16(1): 11–14, doi: 1.2006/JCPSP.1114.
19. Lorenzoni P, Werneck L, Kay C, et al. When should MELAS (Mito-
chondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-
like episodes) be the diagnosis? Arquivos de Neuro-Psiquiatria. 
2015; 73(11): 959–967, doi: 10.1590/0004-282x20150154.
20. Jiang Z, Wu X, Zhu Y. Variant at position 10,055 in mitochon-
drial tRNAGly gene has a negative association with aplastic 
anemia. Mitochondrial DNA Part A. 2015; 27(5): 3086–3088, doi: 
10.3109/19401736.2014.1003921.
21. Martikainen M, Rönnemaa T, Majamaa K. Prevalence of mitochon-
drial diabetes in southwestern Finland: a molecular epidemio-
logical study. Acta Diabet. 2012; 50(5): 737–741, doi: 10.1007/
s00592-012-0393-2.
22. Wang S, Wu S, Zheng T, et al. Mitochondrial DNA mutations in 
diabetes mellitus patients in Chinese Han population. Gene. 2013; 
531(2): 472–475, doi: 10.1016/j.gene.2013.09.019.
23. Abrar S, Muhammad K, Zaman H, et al. Molecular genetic 
analysis of Type II diabetes associated m.3243A>G mitochon-
drial DNA mutation in a Pakistani family. Egyptian Journal of 
Medical Human Genetics. 2017; 18(3): 305–308, doi: 10.1016/j.
ejmhg.2016.12.001.
24. Zambelli A, Vidal-Rioja L. Lack of association between mitochon-
drial DNA mutation np3243 and maternally inherited diabetes 
mellitus. Clinical Biochemistry. 1999; 32(1): 81–82, doi: 10.1016/
s0009-9120(98)00102-7.
25. Rusanen H, Majamaa K, Tolonen U, et al. Demyelinating poly-
neuropathy in a patient with the tRNALeu(uur) mutation at base 
pair 3243 of the mitochondrial DNA. Neurology. 1995; 45(6): 
1188–1192, doi: 10.1212/wnl.45.6.1188.
26. Mohan V, Radha V, Nguyen T, et al. Comprehensive genomic 
analysis identifies pathogenic variants in maturity-onset diabetes 
of the young (MODY) patients in South India. BMC Med Genet. 
2018; 19(1): 22, doi: 10.1186/s12881-018-0528-6.
27. Malecki M, Klupa T, Wanic K, et al. Search for mitochondrial 
A3243G tRNALeu mutation in Polish patients with type 2 diabetes 
mellitus. Med Sci Monit. 2001; 7(2): 246–250; PMID: 421154.
28. Kuzuya T, Matsuda A. Classification of diabetes on the basis of 
etiologies versus degree of insulin deficiency. Diabetes Care. 1997; 
20(2): 219–220, doi: 10.2337/diacare.20.2.219.
29. Lehto M, Tuomi T, Mahtani MM, et al. Characterization of the 
MODY3 phenotype. Early-onset diabetes caused by an insulin 
secretion defect. J Clin Invest. 1997; 99(4): 582–591, doi: 10.1172/
jci119199.
30. Guerra C, Navarro P, Valverde A, et al. Brown adipose tissue–spe-
cific insulin receptor knockout shows diabetic phenotype without 
insulin resistance. J Clin Invest. 2001; 108(8): 1205–1213, doi: 
10.1172/jci13103.
31. Bhirud P. BalasahebBJ. Conceptual study of malnutrition related 
diabetes mellitus. JAIMS. 2019; 4(1): 89–95, doi: https://doi.
org/10.21760/jaims.4.1.18.
32. Rötig A, Cormier V, Chatelain P, et al. Deletion of mitochondrial 
DNA in a case of early-onset diabetes mellitus, optic atrophy, and 
deafness (Wolfram syndrome, MIM 222300). J Clin Invest. 1993; 
91(3): 1095–1098, doi: 10.1172/jci116267.
33. Schober E, Rami B, Grabert M, et al. Phenotypical aspects of matu-
rity-onset diabetes of the young (MODY diabetes) in comparison 
with Type 2 diabetes mellitus (T2DM) in children and adolescents: 
experience from a large multicentre database. Diabet Med. 2009; 
26(5): 466–473, doi: 10.1111/j.1464-5491.2009.02720.x.
34. Catchpole B, Kennedy LJ, Davison LJ, et al. Canine diabetes mel-
litus: from phenotype to genotype. J Small Anim Pract. 2008; 
49(1): 4–10, doi: 10.1111/j.1748-5827.2007.00398.x.
